• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [24339 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2024     WorkSafeBC Causal association between back sprain / strain and spontaneous abortion
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Resuscitative endovascular balloon occlusion of the aorta]
2024     Andalusian Health Technology Assessment Area (AETSA) [Liquid biopsy in lung neoplasms: diagnosis, prognosis and treatment adequacy]
2024     National Institute for Health and Care Excellence (NICE) Belzutifan for treating tumours associated with von Hippel-Lindau disease. NICE technology appraisal guidance 1011
2024     Agency for Care Effectiveness (ACE) Tricuspid transcatheter edge-to-edge repair system for symptomatic severe tricuspid regurgitation
2024     WorkSafeBC Causal association of being a retired firefighter and the development of coronary artery diseases (CAD)
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Endoscopic anti-reflux mucosectomy, ARMS]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Isoflavone: Evidence report for the S3 guideline on peri- and postmenopause - diagnostics and interventions]
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Paclitaxel-coated balloon dilatation in recurrent bulbar urethral strictures]
2024     National Institute for Health and Care Excellence (NICE) Heart failure algorithms for remote monitoring in people with cardiac implantable electronic devices. NICE diagnostics guidance 61
2024     Agency for Care Effectiveness (ACE) Radiolucent fixation rods & screws for patients with primary and metastatic spinal tumours
2024     WorkSafeBC Causal association between exposure to certain chemicals and the development of idiopathic Parkinson's Disease
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Endorectal cooling accompanying prostate cancer surgery]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: imaging of the spine for the investigation of low back pain]
2024     National Institute for Health and Care Excellence (NICE) Digital technologies for assessing attention deficit hyperactivity disorder (ADHD). NICE diagnostics guidance 60
2024     Agency for Care Effectiveness (ACE) Lumbar artificial disc replacement for treatment of patients with lumbar disc degenerative disease
2024     WorkSafeBC Efficacy/effectiveness of prolozone or PEMF in treating shoulder or back strain as well as disc herniation
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Migraine surgery]
2024     NIHR Health Technology Assessment programme Treatment options for patients with pilonidal sinus disease: PITSTOP, a mixed-methods evaluation
2024     National Institute for Health and Care Excellence (NICE) Endoscopic bipolar radiofrequency ablation for malignant biliary obstruction. NICE interventional procedures guidance 794
2024     Agency for Care Effectiveness (ACE) Continuous glucose monitoring systems for children and adults with type 1 diabetes mellitus
2024     WorkSafeBC Pharmacological and psychosocial interventions for ketamine use disorder
2024     The Federal Joint Committee (G-BA) [Pharmaceutical Directive/Annex XII: Sirolimus (facial angiofibroma associated with tuberous sclerosis complex, ≥ 6 years)]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Treatment discussions: Does shared decision-making between doctor and patient regarding the choice of treatment lead to better results?]
2024     NIHR Health Technology Assessment programme Immunogenicity and seroefficacy of pneumococcal conjugate vaccines: a systematic review and network meta-analysis
2024     Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS) [The utility of neuropsychological tests for the detection and diagnosis of frontotemporal dementia (FTD)]
2024     Agency for Care Effectiveness (ACE) Cervical artificial disc replacement for treatment of patients with cervical disc degenerative disease
2024     WorkSafeBC Causal association of neuroendocrine tumors and work duties as a firefighter
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Patient specific aortic graft guidance for open thoracoabdominal aortic repair]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: judicious blood culture use]
2024     NIHR Health Services and Delivery Research programme Understanding how children and young people with chronic non-cancer pain and their families experience living with pain, pain management and services: a meta-ethnography
2024     WorkSafeBC Colon cancer and firefighting
2024     National Evidence-based Healthcare Collaborating Agency (NECA) [Portable automated sputum suction]
2024     The Regional Health Technology Assessment Centre (HTA-centrum) Automated feedback based on digitalized follow-up of patients with unipolar depression receiving pharmacotherapy
2024     NIHR Health Services and Delivery Research programme Using palliative care needs rounds in the UK for care home staff and residents: an implementation science study
2024     WorkSafeBC Causal association on the development of transverse myelitis post mRNA Covid-19 vaccination
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: equivalence of the positivity threshold of immunochemical fecal occult blood tests for colorectal cancer screening]
2024     The Regional Health Technology Assessment Centre (HTA-centrum) Can the postoperative routine of intravenous/oral antibiotics after acute appendectomy in children with perforated appendicitis be shortened?
2024     NIHR Health Services and Delivery Research programme Community First Responders’ role in the current and future rural health and care workforce: a mixed-methods study
2024     WorkSafeBC Dance movement therapy as treatment for post-traumatic stress disorder (PTSD)
2024     The Danish Health Technology Council (DHTC) [Assessment of domiciliary non-invasive ventilation for patients with chronic obstructive pulmonary disease]
2024     NIHR Health Technology Assessment programme Stopping anticoagulation for isolated or incidental pulmonary embolism: the STOPAPE RCT protocol
2024     NIHR Health Services and Delivery Research programme Lessons for the UK on implementation and evaluation of breastfeeding support: evidence syntheses and stakeholder engagement
2024     WorkSafeBC Restless legs syndrome (RLS) and post-traumatic stress disorder (PTSD): 2024 update
2024     NIHR Health Technology Assessment programme Interventions for primary prevention of cardiovascular disease: umbrella review of systematic reviews
2024     NIHR Health Services and Delivery Research programme Digital First Primary Care for those with multiple long-term conditions: a rapid review of the views of stakeholders
2024     WorkSafeBC Best practices for preventing psychological injury to front-line community support workers
2024     NIHR Health Technology Assessment programme Bezafibrate as treatment in males for Barth syndrome: CARDIOMAN, a double-blind, placebo-controlled crossover RCT
2024     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Adaptive deep brain stimulation in Parkinson's disease]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Checklist: screening for cancers, chronic diseases and STBBIs]
2024     NIHR Health Technology Assessment programme Accuracy of glomerular filtration rate estimation using creatinine and cystatin C for identifying and monitoring moderate chronic kidney disease: the eGFR-C study
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: care management for youth under 18 with attention deficit hyperactivity disorder (ADHD)]
2024     WorkSafeBC COVID-19 and multiple sclerosis relapse
2024     NIHR Health Services and Delivery Research programme Causes and solutions to workplace psychological ill-health for nurses, midwives and paramedics: the Care Under Pressure 2 realist review
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: reducing the carbon footprint of anesthetic agents inhaled in the operating room during general anesthesia - strategies and challenges to consider]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Concept for routine practice data collection acc. to the Law for More Safety in the Supply of Medicines (GSAV): talquetamab (multiple myeloma)]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: environmental impacts in health and social services - what role should health technology assessment agencies play?]
2024     WorkSafeBC Low-dose naltrexone as treatment for post-Covid conditions: first update
2024     Penn Medicine Center for Evidence-based Practice (CEP) Renal denervation for treatment of resistant hypertension
2024     National Institute for Health and Care Excellence (NICE) Setmelanotide for treating obesity and hyperphagia in Bardet-Biedl syndrome. NICE highly specialised technologies guidance 31
2024     WorkSafeBC Risk factors associated with the development or acceleration of degenerative disc disease for helicopter pilots - 2024 update
2024     NIHR Health Technology Assessment programme Establishing a research partnership to investigate functional loss and rehabilitation towards the end of life
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Daridorexant (insomnia) – Benefit assessment according to §35a Social Code Book V]
2024     National Institute for Health and Care Excellence (NICE) Sebelipase alfa for treating Wolman disease. NICE highly specialised technologies guidance 30
2024     Health Sciences Institute in Aragon (IACS) [Methods for the quantification of direct-acting oral anticoagulants in plasma]
2024     WorkSafeBC Compartment syndrome and collagen structure
2024     Penn Medicine Center for Evidence-based Practice (CEP) Patient hand hygiene before meals for infection control
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Enalapril (heart failure, children and adolescents) – Benefit assessment according to §35a Social Code Book V]
2024     NIHR Health Services and Delivery Research programme Evaluation of different models of general practitioners working in or alongside emergency departments: a mixed-methods realist evaluation
2024     Canary Health Service [Effectiveness, safety, and cost-effectiveness of out-of-hospital cardiac rehabilitation for ischemic heart disease or heart failure]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Zilucoplan (generalized myasthenia gravis) – Benefit assessment according to §35a Social Code Book V]
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: delirium in elderly persons in emergency departments - prevention, assessment and management]
2024     Canary Health Service [Effectiveness, safety and cost-effectiveness of automated systems for detecting adverse drug reactions]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Nirsevimab (prevention of RSV disease) – Benefit assessment according to §35a Social Code Book V]
2024     NIHR Health Technology Assessment programme Advice only versus advice and a physiotherapy programme for acute traumatic anterior shoulder dislocation: the ARTISAN RCT
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: initiating osteodensitometry following the assessment of fracture risk with the FRAX tool]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Decitabine/cedazuridine (acute myeloid leukaemia) – Benefit assessment according to §35a Social Code Book V]
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Alemtuzumab, cladribine, fingolimod, and natalizumab as first-line treatments in adult patients with highly active relapsing multiple sclerosis
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Rapid response: intravesical treatment for bladder cancer]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idecabtagene vicleucel (multiple myeloma, at least 2 prior therapies) – Benefit assessment according to §35a Social Code Book V]
2024     Canadian Agency for Drugs and Technologies in Health (CADTH) Renal denervation
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Guides and standards: major depressive disorder during pregnancy]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Efgartigimod alfa (generalized myasthenia gravis) – Benefit assessment according to §35a Social Code Book V]
2024     Ontario Health Intrathecal drug delivery systems for cancer pain
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Report: judicious use of medical biology tests in the diagnosis and treatment of Helicobacter pylori infection]
2024     Health Technology Wales (HTW) Artificial Intelligence (AI)-assisted endoscopy in the detection of gastrointestinal cancer and pre-cancerous lesions
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Gadopiclenol (contrast-enhanced magnetic resonance imaging) – Benefit assessment according to §35a Social Code Book V]
2024     Belgian Health Care Knowledge Centre (KCE) The use of endothelial cell count in the preoperative evaluation of cataract surgery
2024     NIHR Health Services and Delivery Research programme Linkage of routinely collected NHS data to evaluate liaison mental health services: challenges and lessons learned
2024     Health Technology Wales (HTW) Artificial intelligence assisted tools for prostate cancer diagnosis using whole slide biopsy images
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Routine practice data collection for etranacogene dezaparvovec (haemophilia B): Review of the study protocol (Version 2.0) and statistical analysis plan (Version 2.0) – Third addendum to Commission A22-83]
2024     Belgian Health Care Knowledge Centre (KCE) Lung cancer screening in a high-risk population
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [Newsletter: genomic medicine in healthcare systems - challenges and opportunities]
2024     Health Technology Wales (HTW) FloSeal in the treatment of epistaxis
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Abaloparatide (osteoporosis, postmenopausal women) – Benefit assessment according to §35a Social Code Book V]
2024     Belgian Health Care Knowledge Centre (KCE) Diagnostic Immunohistochemistry and electron microscopy testing in Belgium
2024     Institut national d'excellence en sante et en services sociaux (INESSS) [State of practice: overview of polypharmacy and use of potentially inappropriate medications among people aged 65 and over in Quebec]
2024     Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Etrasimod (ulcerative colitis) – Benefit assessment according to §35a Social Code Book V]
2024     NIHR Health Technology Assessment programme Point-of-care tests for urinary tract infections to reduce antimicrobial resistance: a systematic review and conceptual economic model
2024     Institute for Clinical Effectiveness and Health Policy (IECS) [Rigid-platform (TEM/ TEO) or flexible-platform (TAMIS) endoscopic transanal surgery for the treatment of rectal lesions]